Clinical and Economic Impact of COVID-19 on Agricultural Workers, Guatemala
COVID-19
Guatemala
SARS-CoV-2
agricultural workers
clinical impact
cohort
coronavirus disease
coronaviruses
economic impact
influenza virus
productivity
respiratory illness impact
respiratory infections
respiratory syncytial virus
severe acute respiratory syndrome coronavirus 2
severity
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
15
12
2022
Statut:
ppublish
Résumé
We evaluated clinical and socioeconomic burdens of respiratory disease in banana farm workers in Guatemala. We offered all eligible workers enrollment during June 15-December 30, 2020, and annually, then tracked them for influenza-like illnesses (ILI) through self-reporting to study nurses, sentinel surveillance at health posts, and absenteeism. Workers who had ILI submitted nasopharyngeal swab specimens for testing for influenza virus, respiratory syncytial virus, and SARS-CoV-2, then completed surveys at days 0, 7, and 28. Through October 10, 2021, a total of 1,833 workers reported 169 ILIs (12.0 cases/100 person-years), and 43 (25.4%) were laboratory-confirmed infections with SARS-CoV-2 (3.1 cases/100 person-years). Workers who had SARS-CoV-2‒positive ILIs reported more frequent anosmia, dysgeusia, difficulty concentrating, and irritability and worse clinical and well-being severity scores than workers who had test result‒negative ILIs. Workers who had positive results also had greater absenteeism and lost income. These results support prioritization of farm workers in Guatemala for COVID-19 vaccination.
Identifiants
pubmed: 36502430
doi: 10.3201/eid2813.212303
pmc: PMC9745239
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S277-S287Références
J Med Virol. 2021 Jul;93(7):4099-4101
pubmed: 33760278
Indian J Occup Environ Med. 2017 Jan-Apr;21(1):2-8
pubmed: 29391741
Emerg Infect Dis. 2021 May;27(5):1323-1329
pubmed: 33724916
Ann Clin Transl Neurol. 2021 May;8(5):1073-1085
pubmed: 33755344
Emerg Infect Dis. 2011 Aug;17(8):1421-9
pubmed: 21801619
Vaccine. 2015 Nov 27;33(48):6537-44
pubmed: 26597032
Am J Epidemiol. 1994 Jun 1;139(11):1055-65
pubmed: 8192138
Am J Trop Med Hyg. 2021 May 10;105(1):93-101
pubmed: 33970888
Pharmacoeconomics. 2008;26(11):911-24
pubmed: 18850761
Emerg Infect Dis. 2021 May;27(5):1525-1527
pubmed: 33596168
Adv Pediatr. 2016 Aug;63(1):357-87
pubmed: 27426907
Value Health. 2011 Jul-Aug;14(5):687-99
pubmed: 21839407
J Am Pharm Assoc (2003). 2017 Jan - Feb;57(1):13-19
pubmed: 27836481
J Neurovirol. 2021 Feb;27(1):191-195
pubmed: 33528824
J Med Internet Res. 2017 Nov 09;19(11):e368
pubmed: 29122738
J Occup Environ Med. 2018 Jun;60(6):548-558
pubmed: 29370016
J Infect Dis. 2013 Dec 15;208 Suppl 3:S197-206
pubmed: 24265479
N Engl J Med. 2019 May 9;380(19):1843-1852
pubmed: 31067373
Pharmacoeconomics. 1999 Nov;16(5 Pt 2):563-76
pubmed: 10662481
Emerg Infect Dis. 2021 May;27(5):1330-1342
pubmed: 33657340
Vaccine. 2007 Jun 28;25(27):5086-96
pubmed: 17544181
Nat Commun. 2021 Jun 8;12(1):3455
pubmed: 34103517
J Clin Virol. 2020 Aug;129:104538
pubmed: 32650276
J Agromedicine. 2020 Oct;25(4):378-382
pubmed: 32945241
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Influenza Other Respir Viruses. 2016 May;10(3):170-5
pubmed: 26701079
PLoS One. 2018 Oct 5;13(10):e0205181
pubmed: 30289894
Euro Surveill. 2021 Oct;26(40):
pubmed: 34622761
BMC Public Health. 2021 Sep 25;21(1):1747
pubmed: 34563163
Bull World Health Organ. 2018 Feb 1;96(2):122-128
pubmed: 29403115
J Infect Dis. 2013 Dec 15;208 Suppl 3:S246-54
pubmed: 24265484